Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-01-05 @ 6:11 PM
Study NCT ID:
NCT04796194
Status:
COMPLETED
Last Update Posted:
2025-11-20
First Post:
2021-03-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma
Sponsor:
Lytix Biopharma AS
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C20-315-05 (ATLAS-IT-05)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None